Low double-digit growth in quarterly medical device sales has pushed Abbott to nudge up its earnings projections for the year. The company’s second-quarter report follows FDA green lights earlier this ...

April 16 (Reuters) - Johnson & Johnson's (JNJ.N), opens new tab first-quarter revenue missed Wall Street estimates for medical devices on Tuesday and sales of its blockbuster psoriasis drug Stelara ...

On Thursday, Baxter International Inc. (NYSE:BAX) reported a first-quarter 2025 adjusted EPS of 62 cents, beating the management guidance of 47 to 50 cents and the Wall Street estimate of 48 cents.

Johnson & Johnson reported first-quarter adjusted earnings that topped expectations as sales in its medical devices business surged. The company is benefiting from a rebound in demand for nonurgent ...

(Reuters) -Abbott Laboratories raised its annual profit forecast and beat Wall Street estimates for second-quarter earnings on Thursday, buoyed by strong sales of its cardiac and diabetes care devices ...

Abbott’s strong medical devices sales boosted the company during the first part of 2024, beating Wall Street expectations and raising its forward-looking financial guidance. The company released its ...

Wednesday, Abbott Laboratories (NYSE:ABT) reported first-quarter sales of $9.96 billion, up 10.8% on an organic basis for the underlying base business, beating the consensus of $9.88 billion. Reported ...

The medical device industry is high-stakes, high-pressure, and largely invisible to the public. In Connective Tissue, veteran ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...